Document Details

(820 K)

THE BIOLOGIC DECAY PERIOD OF SODIUM IN NORMAL MAN, IN PATIENTS WITH CONGESTIVE HEART FAILURE, & IN PATIENTS WITH THE NEPHROTIC SYNDROME AS DETERMINED BY SODIUM-22 AS THE TRACER( CONT'D IN ABSTRACT )

BURCH, G E [TULANE UNIVERSITY]; REASER, P B; THREEFOOT, S A

HREX; SODIUM

Location - DOE/NNSA NUCLEAR TESTING ARCHIVE Address - P.O. Box 98521 City - Las Vegas State - NV Zip - 89193-8521 Phone - (702)794-5106 Fax - (702)862-4240 Email - NTA@NV.DOE.GOV

JOURNAL ARTICLE

1949 Dec 31

Never classified

0013

NV0702754

REYNOLDS ELECTRICAL AND ENGINEERING COMPANY

1994 Aug 27

2012 May 14

(CONT'D FROM TITLE) (JOURNAL OF LABORATORY AND CLINICAL MEDICINE, VOL. 34, 1949, PGS 1-13) (PARTIAL). FAILURE OR FROM CHRONIC GLOMERULONEPHRITIS OF THE NEPHROTIC TYPE. BECAUSE OF THE NATURE OF THE EXPERIMENTS, THE TRUE BIOLOGIC HALF-LIFE PERIOD WAS NOT MEASURED DIRECTLY. INSTEAD, THE TIME NECESSARY TO REDUCE THE SERUM CONCENTRATION TO ONE-HALF THE INITIAL LEVEL AFTER THE ESTABLISHMENT OF EQUILIBRIUM AND THE TIME REQUIRED TO ELIMINATE ONE- HALF THE INJECTED SODIUM-22 IN THE URINE WERE DETERMINED. THE IMPORTANCE OF THESE OBSERVATIONS AND THE RELATIVE GENERAL SIGNIFICANCE OF THESE TIME PERIODS IN THE BIOLOGIC APPLICATION OF RADIOELEMENTS, PARTICULARLY RADIOSODIUM, ARE DISCUSSED.